Accelerate Diagnostics Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Accelerate Diagnostics's estimated revenue is currently $56.7M per year.
- Accelerate Diagnostics's estimated revenue per employee is $234405
- Accelerate Diagnostics has 242 Employees.
- Accelerate Diagnostics grew their employee count by -4% last year.
- Accelerate Diagnostics currently has 1 job openings.
What Is Accelerate Diagnostics?
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Auer Precision ...||$8M||34||6%|
|Life Care Solut...||$9M||39||0%|
Accelerate Diagnostics News
TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second ...
Accelerate Diagnostics (NASDAQ:AXDX) is finally approaching an inflection point in their unit sales of the Pheno system, and hospitals are ...
Accelerate Diagnostics, Inc. (NasdaqCM:AXDX) has an ERP5 rank of 17303. The ERP5 Rank is an investment tool that analysts use to ...